Prostate Cancer - Results from #23440

Docetaxel chemotherapy for Chinese patients with castrate-resistant prostate cancer - Abstract May 22, 2013

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer - Abstract May 22, 2013

Impact of age at diagnosis on outcomes in men with castrate-resistant prostate cancer (CRPC) - Abstract May 22, 2013

Prognostic significance of patterns of seminal vesicle invasion in prostate cancer - Abstract May 22, 2013

Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: Early results - Abstract May 22, 2013

New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication - Abstract May 22, 2013

Review of the economic evaluations of hormonal therapy for patients with locally advanced prostate cancer - Abstract May 22, 2013

Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancer - Abstract May 22, 2013

IMRT may not be more effective than older radiation techniques after prostatectomy May 21, 2013

No-treatment approach may be best choice for older prostate cancer patients May 21, 2013

Does robotic prostatectomy meet its promise in the management of prostate cancer? - Abstract May 21, 2013

A reference set of health utilities for long-term survivors of prostate cancer: Population-based data from Ontario, Canada - Abstract May 21, 2013

Comparison of biochemical recurrence free survival between periprostatic and pelvic lymph node metastases of prostate cancer - Abstract May 21, 2013

Multiparametric MR imaging for detection of clinically significant prostate cancer: A validation cohort study with transperineal template prostate mapping as the reference standard - Abstract May 21, 2013

Delayed radiotherapy for patients with localized prostate cancer: Validation by propensity score matching - Abstract May 21, 2013

Improved therapeutic targeting of the androgen receptor: Rational drug design improves survival in castration-resistant prostate cancer - Abstract May 21, 2013

Feasibility and radiation induced toxicity regarding the first application of transperineal implementation of biocompatible balloon for high dose radiotherapy in patients with prostate carcinoma - Abstract May 21, 2013

Dietary supplements and prostate cancer: A systematic review of double-blind, placebo-controlled randomised clinical trials - Abstract May 21, 2013

Statin use and risk of prostate cancer and high-grade prostate cancer: Results from the REDUCE study - Abstract May 21, 2013

Optimal therapy sequencing in metastatic castration-resistant prostate cancer - Abstract May 21, 2013

Page 1173 of 1450